Likes
The working culture and due respect to every employee by seniors, Management is supportive and helpful. Family and Professional work balance. Job longevity and security.
read moreCompany name | Avg Annual Salary | Open Jobs |
---|---|---|
Cipla Ipqa Officer Salary
0 - 4 years exp. (16 salaries) | ₹1.1 L/yr - ₹3.4 L/yr
28%
more | |
Sun Pharmaceutical Industries Ipqa Officer Salary
0 - 4 years exp. (21 salaries) | ₹1.7 L/yr - ₹3.8 L/yr
60%
more | |
Login to view exact salary
| ||
Torrent Pharmaceuticals Ipqa Officer Salary
1 - 5 years exp. (11 salaries) | ₹2.3 L/yr - ₹4 L/yr
69%
more | |
Lupin Ipqa Officer Salary
1 - 7 years exp. (47 salaries) | ₹1.7 L/yr - ₹5.5 L/yr
114%
more | |
Zydus Lifesciences Ipqa Officer Salary
1 - 4 years exp. (27 salaries) | ₹1.9 L/yr - ₹5.2 L/yr
51%
more | |
Glenmark Pharmaceuticals Ipqa Officer Salary
0 - 5 years exp. (38 salaries) | ₹2.5 L/yr - ₹4.6 L/yr
71%
more | |
Aurobindo Pharma Ipqa Officer Salary
0 - 7 years exp. (9 salaries) | ₹2.7 L/yr - ₹5.1 L/yr
108%
more | |
NecLife Ipqa Officer Salary
2 - 7 years exp. (9 salaries) | ₹2.4 L/yr - ₹4.1 L/yr
76%
more | |
Unichem Laboratories Ipqa Officer Salary
2 - 5 years exp. (8 salaries) | ₹3.2 L/yr - ₹4.8 L/yr
91%
more | |
Granules India Ipqa Officer Salary
0 - 3 years exp. (7 salaries) | ₹2.3 L/yr - ₹3.2 L/yr
51%
more | |
Sanofi Ipqa Officer Salary
0 - 1 year exp. (6 salaries) | ₹2.1 L/yr - ₹2.5 L/yr
23%
more | |
Login to view exact salary
| ||
Eris Lifesciences Ipqa Officer Salary
1 - 3 years exp. (5 salaries) | ₹1.7 L/yr - ₹3.5 L/yr
28%
more | |
Natco Pharma Ipqa Officer Salary
3 - 8 years exp. (4 salaries) | ₹2.3 L/yr - ₹4.8 L/yr
97%
more | |
Medley Pharmaceuticals Ipqa Officer Salary
2 - 6 years exp. (4 salaries) | ₹3.2 L/yr - ₹4.4 L/yr
96%
more | |
Ind-Swift Laboratories Ipqa Officer Salary
1 - 3 years exp. (4 salaries) | ₹2 L/yr - ₹2.5 L/yr
23%
more | |
Lincoln Pharmaceuticals Ipqa Officer Salary
1 - 6 years exp. (4 salaries) | ₹2.5 L/yr - ₹3.3 L/yr
53%
more | |
Discover interview dos and don'ts from real experiences
Top trending discussions